Immune Regulation Announces $53 Million Dollar Financing Led By Morningside Ventures
Below is our recent interview with Jonathan M.N. Rigby, CEO of Immune Regulation: Q: For those who have never heard of it, how would you describe Immune Regulation? A: Immune Regulation is a clinical stage biotech company, pioneering new...